Ipilimumab, nivolumab and tocilizumab as first-line therapy for advanced melanoma.

标题
Ipilimumab, nivolumab and tocilizumab as first-line therapy for advanced melanoma.
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 39, Issue 15_suppl, Pages TPS9589-TPS9589
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2021-06-02
DOI
10.1200/jco.2021.39.15_suppl.tps9589

向作者/读者发起求助以获取更多资源

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started